nt4.zacks.com Historical Stock Price DISCLOSURES. The following disclosures relate to relationships between Zacks Small-Cap Research (“Zacks SCR”), a division of Zacks Investment Research (“ZIR”), and the issuers covered by the Zacks SCR Analysts in the Small-Cap Universe. BLPH: Zacks Company Report. Bellerophon Therapeutics, Inc. (BLPH) - Common Stock ... Common Stock Dividends Paid: The cash outflow for dividends paid on a company's common stock. Bellerophon Therapeutics, Inc. (BLPH) Common Stock Dividends Paid data is not available. Quarterly Annual. Figures for fiscal quarter ending 2020-03-31 Data from Zacks Investment Research, Inc. Get the latest Bellerophon Therapeutics Inc BLPH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Bellerophon Therapeutics, Inc. - BLPH - Stock Price Today - Zacks BLPH is Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results. (BLPH) Zacks News . Zacks News. Company Should I buy Bellerophon Therapeutics, Inc. (BLPH)? Use the Zacks Rank and Style Scores to find out is BLPH is right for your portfolio.
View information about BLPH with charts, fundamental and technical data together 2019-12-17 08:44:00 | Bellerophon stock is up 35% on hypertension trial data 2019-08-06 20:15:00 | BLPH: Zacks SCR Initiates Coverage of Bellerophon
Bellerophon Therapeutics. BLPH 12.87 0.08 (0.63%). NASDAQ Updated Jun 8, 2020 8:39 PM Latest news headlines for Bellerophon Ther Com with market analysis and analyst commentary. Bellerophon Ther Com (BLPH) [[ item.lastPrice ]] 2020 Zacks Equity Research - Zacks Investment Research - Tue May 12, 9:09AM CDT. Zacks Equity Research - ZACKS - Tue May 12, 9:09AM CDT Bellerophon Therapeutics Announces Closing of $43.7 Million Public Offering of Common Stock and Concurrent Registered Direct Offering and Full Exercise of Option to Purchase Additional Shares. GlobeNewswire +7.99%. BLPH: Zacks SCR Initiates Coverage of Bellerophon Therapeutics. Zacks Small Cap Research. View Bellerophon Therapeutics Inc BLPH investment & stock information. Get the latest Bellerophon Therapeutics Inc BLPH detailed stock quotes, stock data, Inc. (BLPH)? Use the Zacks Rank and Style Scores to find out is BLPH is right for your portfolio. View All Zacks #1 Ranked Stocks. Trades from $1. BLPH: Bellerophon Therapeutics Inc broker recommendation chart. Get the latest chart with View All Zacks #1 Ranked Stocks. Trades from $1. The Zacks
View information about BLPH with charts, fundamental and technical data together 2019-12-17 08:44:00 | Bellerophon stock is up 35% on hypertension trial data 2019-08-06 20:15:00 | BLPH: Zacks SCR Initiates Coverage of Bellerophon
Bellerophon Therapeutics (BLPH) Stock Price History | wallmine Bellerophon Therapeutics, Inc. focuses on developing products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline include PH-ILD, PH-COPD, and PH-Sarc. The company was founded in … Bellerophon Therapeutics Inc. (Nasdaq: BLPH) :: LD Micro Bellerophon Therapeutics Announces Closing of $43.7 Million Public Offering of Common Stock and Concurrent Registered Direct Offering and Full Exercise of Option to Purchase Additional Shares: 05/19/2020 07:00 AM EDT: GlobeNewswire : Bellerophon Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Registered Direct
BLPH - Bellerophon Ther Com Stock Price - Barchart.com
Bellerophon Therapeutics Announces Closing of $43.7 Million Public Offering of Common Stock and Concurrent Registered Direct Offering and Full Exercise of Option to Purchase Additional Shares. GlobeNewswire +7.99%. BLPH: Zacks SCR Initiates Coverage of Bellerophon Therapeutics. Zacks Small Cap Research. View Bellerophon Therapeutics Inc BLPH investment & stock information. Get the latest Bellerophon Therapeutics Inc BLPH detailed stock quotes, stock data, Inc. (BLPH)? Use the Zacks Rank and Style Scores to find out is BLPH is right for your portfolio. View All Zacks #1 Ranked Stocks. Trades from $1. BLPH: Bellerophon Therapeutics Inc broker recommendation chart. Get the latest chart with View All Zacks #1 Ranked Stocks. Trades from $1. The Zacks BLPH: Bellerophon Therapeutics Inc options chain stock quote. Get the latest options chain stock quote information from Zacks Investment Research. BLPH: Bellerophon Therapeutics Inc price and EPS surprise. Get the latest price and EPS View All Zacks #1 Ranked Stocks. Trades from $1. The Zacks Equity
Bellerophon Therapeutics Inc (NASDAQ:BLPH) has received a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the company, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy recommendation. Brokerages have set a twelve-month consensus target price of $35.93 for the company and […]
BLPH Bellerophon Therapeutics, Inc. Stock Quote Zacks Small Cap Research-15.89% Oct-23-19 08:30AM Bellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting